Skip to content

    Health & Pregnancy

    Font Size
    A
    A
    A

    Common Treatment to Prevent Recurrent Miscarriage Doesn't Work

    By
    WebMD Health News

    Nov. 16, 1999 (Minneapolis) -- A widely used form of immunotherapy does not protect against recurrent miscarriage and in fact may increase the risk of pregnancy loss, according to a study in a recent issue of The Lancet. In the study, the controversial procedure -- called mononuclear-cell immunization -- had no benefit over placebo. Therefore, this therapy "should not be offered as a treatment for pregnancy loss," the authors write.

    Most women who have miscarriages have one or two; however, about 1% of couples experience three or more. Although the cause is usually unknown, some investigators have suggested that the pregnant women may have an immune-system defect that causes their bodies to "reject" the fetus through miscarriage.

    In a healthy pregnancy, the mother develops immune-system responses that allow the pregnancy to continue. If this doesn't happen, the mother's body perceives the fetus as foreign material and rejects it -- a phenomenon known as recurrent miscarriage. Without medical intervention, this will continue to happen with each new pregnancy.

    To prevent recurrent miscarriage, mononuclear-cell immunization is offered by many medical centers in the U.S. and around the world. With this therapy, the mother is immunized with white blood cells from the baby's father, on the theory that this immunization will "override" the mother's own immune response to the pregnancy. However, the effectiveness of this technique has been in question due to conflicting results of clinical studies. The findings of the reported study support the opinion that mononuclear-cell immunization doesn't work.

    "These findings should finally put closure to a very controversial treatment for recurrent miscarriage," researcher Carole Ober, PhD, tells WebMD. "The treatment is not effective. ... However, the good news is that the success rate was quite good in the control group -- 65% among women who became pregnant. This is great news for couples with recurrent miscarriage and confirms the impression of many that there isn't anything wrong in most couples with unexplained recurrent miscarriage. With the appropriate medical and emotional support, most of these couples will have a baby in their next pregnancy."

    Of the 183 women in the randomized study -- designed to test the effectiveness of paternal mononuclear-cell immunization -- 91 were assigned to the treatment group; 92 were assigned to the placebo group and received sterile saline. All the women had had at least three miscarriages of unknown cause.

    Pregnancy Week-By-Week Newsletter

    Delivered right to your inbox, get pictures and facts on
    what to expect each week of your pregnancy.

    Today on WebMD

    hand circling date on calendar
    Track your most fertile days.
    woman looking at ultrasound
    Week-by-week pregnancy guide.
     
    Pretty pregnant woman timing contaction pains
    The signs to watch out for.
    pregnant woman in hospital
    Are there ways to do it naturally?
     
    slideshow fetal development
    Slideshow
    pregnancy first trimester warning signs
    Article
     
    What Causes Bipolar
    Video
    Woman trying on dress in store
    Slideshow
     
    pregnant woman
    Article
    Woman looking at pregnancy test
    Quiz
     
    calendar and baby buggy
    Tool
    dark chocolate squares
    Slideshow